Astaxanthin suppresses End MT by LOX-1 pathway in ox-LDL-induced HUVECs
Introduction Astaxanthin (ASX) is carotenoid with the highest antioxidant activity in various cell types and reverse atherosclerosis. However, the roles and detailed mechanisms of ASX in atherosclerosis associated endothelial injury remains unclear. Methods In vitro atherosclerosis model was establi...
Main Authors: | Zhongsheng Zhu, Jinyu Li, Rui Tong, Xiaorong Zhang, Bo Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X221105131 |
Similar Items
-
LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs
by: Gao Hongmei, et al.
Published: (2021-01-01) -
The protective effects of aloperine against ox-LDL-induced endothelial dysfunction and inflammation in HUVECs
by: Weiwei Li, et al.
Published: (2020-01-01) -
Novel H2S donor proglumide-ADT-OH protects HUVECs from ox-LDL-induced injury through NF-κB and JAK/SATA pathway
by: Ou Xuelan, et al.
Published: (2021-09-01) -
LncRNA FGD5-AS1 reduces ox-LDL-induced damage of HUVECs by targeting miR-106a-5p
by: GUO Jing, LI Ya-jie, MOU Han-shuang
Published: (2022-05-01) -
LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects
by: Felix Duprat, et al.
Published: (2023-03-01)